Total Payments
$26,548
2024 Payments
$4,780
Companies
81
Transactions
1,554
Medicare Patients
29,233
Medicare Billing
$4.1M
Payment Breakdown by Category
Food & Beverage$25,915 (97.6%)
Education$620.69 (2.3%)
Gifts$13.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,915 | 1,535 | 97.6% |
| Education | $620.69 | 18 | 2.3% |
| Gift | $13.02 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,692 | 208 | $0 (2024) |
| Novo Nordisk Inc | $2,137 | 157 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,975 | 124 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,684 | 67 | $0 (2024) |
| Lilly USA, LLC | $1,645 | 116 | $0 (2024) |
| Amgen Inc. | $1,557 | 90 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,407 | 111 | $0 (2023) |
| PFIZER INC. | $815.69 | 62 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $774.95 | 29 | $0 (2024) |
| GENZYME CORPORATION | $609.20 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,780 | 214 | AstraZeneca Pharmaceuticals LP ($1,113) |
| 2023 | $4,259 | 224 | AstraZeneca Pharmaceuticals LP ($1,138) |
| 2022 | $3,865 | 225 | AstraZeneca Pharmaceuticals LP ($867.76) |
| 2021 | $2,938 | 190 | AstraZeneca Pharmaceuticals LP ($420.44) |
| 2020 | $2,276 | 149 | AstraZeneca Pharmaceuticals LP ($386.69) |
| 2019 | $2,740 | 170 | AstraZeneca Pharmaceuticals LP ($370.08) |
| 2018 | $2,284 | 191 | Merck Sharp & Dohme Corporation ($385.39) |
| 2017 | $3,408 | 191 | Lilly USA, LLC ($514.64) |
All Payment Transactions
1,554 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.80 | General |
| Category: Narcoplepsy | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $117.32 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Immunology | ||||||
| 12/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Insomnia | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $122.56 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/25/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 61 | 9,526 | 20,923 | $2.9M | $1.3M |
| 2022 | 53 | 7,816 | 16,042 | $2.4M | $1.0M |
| 2021 | 43 | 6,144 | 13,304 | $2.1M | $932,757 |
| 2020 | 46 | 5,747 | 11,559 | $1.6M | $790,513 |
Total Patients
29,233
Total Services
61,828
Medicare Billing
$4.1M
Procedure Codes
203
All Medicare Procedures & Services
203 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 831 | 2,347 | $575,015 | $235,434 | 40.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 313 | 2,664 | $378,030 | $181,469 | 48.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 390 | 2,312 | $161,840 | $126,419 | 78.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 318 | 2,530 | $240,350 | $109,169 | 45.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 106 | 728 | $136,800 | $74,491 | 54.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 252 | 1,532 | $183,840 | $71,314 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 461 | 461 | $112,675 | $66,038 | 58.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 274 | 277 | $107,385 | $47,765 | 44.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 260 | 348 | $85,260 | $38,990 | 45.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 474 | 542 | $83,930 | $36,288 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 253 | 394 | $69,370 | $29,175 | 42.1% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 188 | 192 | $70,340 | $26,217 | 37.3% |
| 93931 | Ultrasound of one arm arteries or artery grafts | Office | 2023 | 274 | 277 | $69,765 | $25,270 | 36.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 175 | 522 | $46,980 | $18,101 | 38.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 93 | 104 | $39,490 | $17,932 | 45.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 229 | 239 | $26,290 | $17,103 | 65.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 304 | 492 | $63,000 | $16,404 | 26.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 62 | 65 | $31,860 | $14,428 | 45.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 50 | 50 | $16,000 | $14,145 | 88.4% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 118 | 120 | $25,200 | $12,568 | 49.9% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 113 | 132 | $19,800 | $12,392 | 62.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 70 | 78 | $29,020 | $11,648 | 40.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 176 | 225 | $18,640 | $11,313 | 60.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 55 | 61 | $22,530 | $11,043 | 49.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 40 | 42 | $19,800 | $10,160 | 51.3% |
About Dr. Jehad Saliba, MD
Dr. Jehad Saliba, MD is a Internal Medicine healthcare provider based in Kearny, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164480372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jehad Saliba, MD has received a total of $26,548 in payments from pharmaceutical and medical device companies, with $4,780 received in 2024. These payments were reported across 1,554 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($25,915).
As a Medicare-enrolled provider, Saliba has provided services to 29,233 Medicare beneficiaries, totaling 61,828 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 203 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Kearny, NJ
- Active Since 05/04/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164480372
Products in Payments
- FASENRA (Biological) $1,355
- JARDIANCE (Drug) $1,295
- FARXIGA (Drug) $1,079
- Ozempic (Drug) $988.16
- DUPIXENT (Biological) $979.90
- TRULICITY (Drug) $725.16
- JANUVIA (Drug) $723.78
- XARELTO (Drug) $635.28
- ACTHAR (Biological) $599.34
- TRELEGY ELLIPTA (Drug) $548.74
- Rybelsus (Drug) $512.93
- XIFAXAN (Drug) $509.18
- AREXVY (Drug) $491.47
- ELIQUIS (Drug) $486.49
- NUCALA (Biological) $466.96
- PURIFIED CORTROPHIN GEL (Drug) $437.48
- QUVIVIQ (Drug) $385.65
- MOUNJARO (Drug) $381.96
- Repatha (Biological) $377.75
- AIRSUPRA (Drug) $377.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kearny
Gary Cardiello, Md, MD
Internal Medicine — Payments: $12,383
Internal Medicine $12,383
Dr. Thomas Francis, D.o, D.O
Internal Medicine — Payments: $9,319
Internal Medicine $9,319
Dr. Richard Romano, Do, Dc, DO, DC
Internal Medicine — Payments: $619.58
Internal Medicine $619.58
Prakash Doshi, M.d, M.D
Internal Medicine — Payments: $601.50
Internal Medicine $601.50
Dr. Mudassar Sharif, M.d, M.D
Internal Medicine
Internal Medicine
Salvatore Rifici, Md, MD
Internal Medicine
Internal Medicine